- Home
- FEBO vs SSKN Comparison
FEBO vs SSKN Comparison
Compare FEBO & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEBO
- SSKN
- Stock Information
- Founded
- FEBO 1993
- SSKN 1989
- Country
- FEBO Hong Kong
- SSKN United States
- Employees
- FEBO 280
- SSKN N/A
- Industry
- FEBO
- SSKN Medical/Dental Instruments
- Sector
- FEBO
- SSKN Health Care
- Exchange
- FEBO Nasdaq
- SSKN Nasdaq
- Market Cap
- FEBO 8.0M
- SSKN 8.9M
- IPO Year
- FEBO 2023
- SSKN 2005
- Fundamental
- Price
- FEBO $0.72
- SSKN $1.82
- Analyst Decision
- FEBO
- SSKN Strong Buy
- Analyst Count
- FEBO 0
- SSKN 1
- Target Price
- FEBO N/A
- SSKN $6.00
- AVG Volume (30 Days)
- FEBO 21.0K
- SSKN 44.0K
- Earning Date
- FEBO 08-26-2025
- SSKN 08-13-2025
- Dividend Yield
- FEBO N/A
- SSKN N/A
- EPS Growth
- FEBO N/A
- SSKN N/A
- EPS
- FEBO N/A
- SSKN N/A
- Revenue
- FEBO $17,110,653.00
- SSKN $32,848,000.00
- Revenue This Year
- FEBO N/A
- SSKN $3.31
- Revenue Next Year
- FEBO N/A
- SSKN $9.67
- P/E Ratio
- FEBO N/A
- SSKN N/A
- Revenue Growth
- FEBO 11.58
- SSKN 0.36
- 52 Week Low
- FEBO $0.66
- SSKN $1.78
- 52 Week High
- FEBO $8.50
- SSKN $3.79
- Technical
- Relative Strength Index (RSI)
- FEBO 30.30
- SSKN 36.69
- Support Level
- FEBO $0.70
- SSKN $1.89
- Resistance Level
- FEBO $0.78
- SSKN $1.95
- Average True Range (ATR)
- FEBO 0.08
- SSKN 0.10
- MACD
- FEBO -0.01
- SSKN 0.00
- Stochastic Oscillator
- FEBO 14.40
- SSKN 13.79
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.